Live On CNBC, Kevin Simpson Announces Bought More AbbVie; Bought More Amgen
Live On CNBC, Kevin Simpson Announces Bought More AbbVie; Bought More Amgen
View filing at SEC.gov →7 most recent filings and news items mentioning ABBV. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/ABBV/news?limit=20"
Pull ABBV filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayLive On CNBC, Kevin Simpson Announces Bought More AbbVie; Bought More Amgen
View filing at SEC.gov →AbbVie Inc. has entered into a definitive merger agreement to acquire Apogee Therapeutics, Inc. through a subsidiary merger structure. The transaction expands AbbVie's therapeutic pipeline and represents a significant M&A activity in the pharmaceutical sector.
View filing at SEC.gov →AbbVie announced a definitive agreement to acquire Apogee Therapeutics for $135.11 per share, totaling approximately $10.9 billion in equity value. The acquisition adds a clinical-stage immunology pipeline focused on inflammatory and immunological diseases including atopic dermat
View filing at SEC.gov →AbbVie Expands Immunology Footprint With Apogee $11 Billion Acquisition
View filing at SEC.gov →7 Health Care Stocks With Whale Alerts In Today's Session
View filing at SEC.gov →AbbVie, UnitedHealth, Sabra Health Care And A Consumer Defensive Stock On CNBC's 'Final Trades'
View filing at SEC.gov →CNBC Halftime Report Final Trades: Coca-Cola, AbbVie, UnitedHealth Group, Sabra Health Care REIT
View filing at SEC.gov →